Forte Biosciences (FBRX) IV bid into data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM (IBM) call put ratio 1.2 calls to 1 put into quarter results
- Bloom Energy Corp. (BE) call put ratio 1.4 calls to 1 put as share price down 2.9%
- Sandisk (SNDK) call put ratio 1.4 calls to 1 put as share price down 3.8%
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
